Kuala Lumpur, 1 June 2026 – Karex Berhad may receive some earnings relief from a reduction in U.S. tariffs, but the world’s largest condom manufacturer is still expected to remain loss-making in the near term as foreign exchange pressure, weaker sales volumes and elevated operating costs continue to weigh on margins.
According to CIMB Securities, the tariff adjustment could provide Karex with an estimated RM8 million boost, offering partial relief after a difficult operating period marked by higher import duties, a stronger ringgit and softer demand in selected export markets.
Unlock the Full Article
This article is exclusive to The Ledger Asia Subsribers / PAID members.
Already have an account? Log in here
